This study is being done to examine the safety and effectiveness of pacritinib as a possible treatment for participants with Waldenström macroglobulinemia (WM)…

Waldenström MacroglobulinemiaLymphoplasmacytic LymphomaB-Cell Lymphoproliferative Disorder+1 more

~Estimated

~$10 – $7,500

Shayna Sarosiek, MDNCT06986174

Phase 2

A Phase 2 Trial Investigating Epcoritamab in Patients With Previously Treated Waldenstrom Macroglobulinemia (WM)

This study is being done to determine if epcoritamab can be used to treat participants with previously treated Waldenstrom Macroglobulinemia (WM). The names o…

Waldenstrom MacroglobulinemiaB-Cell Lymphoproliferative Disorder

~Estimated

~$10 – $7,500

Gottfried von Keudell, MD PhDNCT06510491